Epilepsy Market: Pharma companies heavily invest in R&D for patenting drug.

1
Epilepsy - Pipeline Review, H2 2015
Published on - 11 November, 2015 No of
Pages 372  Single User Price 2000
Epilepsy Market The US is the leading region
due to high market shares in upcoming years
Click Here To Check Complete Report
2

• Epilepsy is a neurological condition where the
  patient experiences uncontrollable seizures.
  There is no permanent cure for epilepsy.
• Epilepsy is one of the common neurological
  conditions. The Epilepsy Market deals with the
  demand and supply of the current epilepsy drug
  and treatment, production and scope of innovation
  of new drug in upcoming years.
• The Epilepsy Market is heavily invested by North
  America and Europe for research and development
  of treatment for the seizure condition.
• A considerable chunk of people in the region
  suffer from epilepsy seizures due to various
  reasons such as genetically or due to an injury.

3

• The APAC is the largest market for the Epilepsy
  market with high population. As the population in
  this region is high, so is the concentration of
  people suffering from this neurological condition
  called epilepsy. The APAC is expected to witness
  the highest growth in the market with high sales
  of epilepsy drug in upcoming years.
• The Epilepsy Market at present has various drugs
  like felbatol, gabitril, keppra, lamictal,
  lyrica, Neurontin, Topamax, trileptal, zonegran
  etc. these drugs have some side effects. The
  research for better drug is constant by companies
  and medical institutes, to reduce the intensity
  or the frequency of occurrence of seizures among
  the epilepsy patients.
• Some of the key players in the Epilepsy Market,
  that produce drug for global outreach are as
  follows
• Johnson Johnson
• UCB Pharma
• Abbott Laboratories
• GlaxoSmithKline
• Pfizer

4
Download Sample Brochure
These companies heavily invest in the Epilepsy
Market for discovering effective drug for
epilepsy and treatment for long term suffering.
After production of the drug, it is sent to
various laboratories and medical facilities for
test, only after test they are approved for
distribution among common population. The
Epilepsy Market is a rapidly growing market with
high demand across the globe in upcoming years.
With the rising cases of epilepsy and lack of
permanent treatment or long term medication, the
epilepsy research is on rise for proper treatment
of the disease. This market is profitable for
investment and will generate high revenue income
in upcoming years.
Make an Inquiry Before Buying
5
Epilepsy - Pipeline Review, H2 2015
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the Epilepsy Market and future opportunities are
provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Epilepsy Market
Report